7658 results for Latest OmniStudio-Consultant Exam Answers 😻 OmniStudio-Consultant Real Questions 💾 OmniStudio-Consultant Valid Guide Files 🎂 Easily obtain free download of ➽ OmniStudio-Consultant 🢪 by searching on ▛ www.pdfvce.com ▟ 😚Current OmniStudio-Consultant Exam Content

Risk of COVID-19 in HCWs working in ICU vs non-ICU settings

Editor's Note This study from Saudi Arabia finds that nurses working in the intensive care unit (ICU) had a significantly higher risk of COVID-19 infection. A total of 1,594 healthcare workers (HCWs) with COVID-19 infections were analyzed—103 working in the ICU and 1,491 working in non-ICU locations. The ICU had…

Read More

By: Judy Mathias
September 1, 2022
Share

New Joint Commission Speak Up program on telehealth

Editor's Note The Joint Commission on August  31 announced a new patient safety campaign to help patients understand telehealth visits, titled: “Speak Up At Your Telehealth Visit.” Educational resources for the Speak Up program include: an infographic poster/flyer an animated video a distribution guide on how to provide the materials…

Read More

By: Judy Mathias
September 1, 2022
Share

Hospitals seeing worst margins since beginning of pandemic, Cleveland Clinic posts near $1B loss

Editor's Note In this National Hospital Flash Report, published in August 2022 by healthcare consulting company Kaufman, Hall and Associates, LLC, experts say “that 2022 is shaping up to be the worst year financially for US hospitals and health systems since the beginning of the COVID-19 pandemic,” Becker’s Hospital CFO…

Read More

By: Tarsilla Moura
August 31, 2022
Share

Efficacy of metformin, ivermectin, fluvoxamine for COVID-19

Editor's Note This phase 3, double-blind, randomized, placebo-controlled study led by researchers at the University of Minnesota, Minneapolis, finds that none of three medications evaluated—metformin, ivermectin, or fluvoxamine—prevented the occurrence of a primary event—hypoxemia, an emergency department (ED) visit, hospitalization, or death—associated with COVID-19. Of 1,323 patients analyzed, a primary…

Read More

By: Judy Mathias
August 31, 2022
Share

FDA: Class I recall of Intera 3000 Hepatic Artery Infusion Pump

Editor's Note The Food and Drug Administration on August 29 identified the recall by Intera Oncology of its Intera 3000 Hepatic Artery Infusion Pump as Class I, the most serious. The company is recalling the pumps after receiving reports from clinicians that the pumps were delivering medication faster than expected.…

Read More

By: Judy Mathias
August 31, 2022
Share

Advanced Rates end on September 29

By: Lindsay Botts
August 30, 2022
Share

Moral distress in healthcare providers working in safety net practices during COVID-19

Editor's Note This study led by researchers at the University of North Carolina School of Medicine, Chapel Hill, finds that nearly 72% of healthcare providers in US safety net practices experienced either mild or intense levels of moral distress during the first year of COVID-19 because of issues with patient…

Read More

By: Judy Mathias
August 30, 2022
Share

ECRI announces guidance on supporting healthcare worker resilience

Editor's Note ECRI, on August 29, announced its new guidance on “Supporting Resilience in Healthcare Workers” that was published on August 15 for its members. With a new focus on protecting healthcare workers against burnout and other behavioral health issues, new strategies for protecting and maintaining resilience have emerged, ECRI…

Read More

By: Judy Mathias
August 30, 2022
Share

Free at-home COVID-19 tests distribution to end this Friday

Editor's Note  On Friday, September 2, the US government will stop giving away free at-home COVID-19 tests because of insufficient congressional funds, according to a senior Biden administration official, NBC News August 28 reports. The White House official said unless there is a surprise round of funding from Congress, the…

Read More

By: Lauren McCaffrey
August 30, 2022
Share

Moderna sues Pfizer and BioNTech for COVID-19 vaccine patent infringement

Editor's Note On Friday, August 26, the vaccine manufacturer Moderna sued Pfizer and the German drugmaker BioNTech, accusing its competitors of copying technology that Moderna had developed prior to the pandemic, The New York Times August 26 reports. The patent infringement claims could result in a protracted and expensive legal battle…

Read More

By: Lauren McCaffrey
August 29, 2022
Share
Live chat by BoldChat